查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1990447

動脈瘤夾市場：2026-2032年全球市場預測（依手術技術、材料、夾子類型、應用、最終用戶和分銷管道分類）

Aneurysm Clips Market by Surgical Technique, Material, Clip Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年動脈瘤夾市場價值為 8,720 萬美元，預計到 2026 年將成長至 9,207 萬美元，複合年成長率為 6.46%，到 ​​2032 年將達到 1.3519 億美元。

主要市場統計數據
基準年 2025 8720萬美元
預計年份：2026年 9207萬美元
預測年份：2032年 1.3519億美元
複合年成長率 (%) 6.46%

對影響動脈瘤夾市場和器械採用的臨床、技術和採購因素進行關鍵性介紹性說明。

動脈瘤夾閉術仍然是神經外科治療方法中至關重要的環節，它融合了數十年的技術改進以及材料和手術流程的持續創新。隨著臨床醫生在開放手術的優勢與不斷發展的微創技術之間尋求平衡，人們越來越關注那些能夠最大限度地提高閉塞可靠性，同時最大限度減少對周圍組織損傷和影像偽影的器械。影像學、神經導航和術中監測技術的同步進步，不僅提高了動脈瘤夾選擇和放置的精確度，也提高了與數位化手術工作流程的兼容性要求。

對重塑動脈瘤夾產品開發和部署模式的關鍵技術、監管和商業性變化進行分析概述。

在技​​術融合和臨床偏好不斷演變的驅動下，動脈瘤夾閉器材正經歷一系列變化。隨著微創和影像導引介入治療的日益普及，製造商正在重新思考夾子的形態、滲透性和人體工學設計，以實現更快、更可靠的定位。同時，諸如改良鈦合金和聚合物複合材料等材料的創新正在減少影像偽影並提高生物相容性，從而改變圍手術全期工作流程和術後影像策略。

重點評估 2025 年新的收費系統將如何影響所有相關人員。

2025年新關稅措施的實施將進一步加劇醫療設備相關人員現有供應鏈的複雜性，因此亟需對籌資策略進行快速重新評估。進口關稅的增加正在影響海外供應商零件和成品的供應，一些製造商正在考慮將生產轉移到近岸地區或擴大國內產能，以此來控制總體成本並最大限度地降低未來政策變化帶來的風險。同時，經銷商和醫院採購團隊正在審查合約條款，以減輕利潤率下降的影響並維持服務水準。

策略性細分洞察，解釋了應用、手術技術、最終用戶、分銷、材料和夾子類型如何影響臨床和商業性重點。

市場區隔為將宏觀趨勢轉化為目標產品和商業策略提供了關鍵觀點。當以應用領域（區分顱內和周邊應用）分析市場時，設計重點也會隨之改變。顱內應用需要極高的精準控制、低輪廓外形和影像相容性，而周邊應用則更注重穩健性、多樣化的尺寸選擇以及基於血管解剖結構的可操作性。相較之下，依手術入路（涵蓋血管內手術和開放手術）進行細分則會為器械的演進開闢不同的路徑。血管內手術強調與導航系統和基於導管的輔助裝置的兼容性，而開放性手術則對機械可靠性和觸覺回饋有著嚴格的要求。

區域分析：重點分析美洲、歐洲、中東、非洲和亞太地區在監管、臨床引入和商業性趨勢方面的差異。

區域趨勢正以不同的方式影響創新路徑和商業性實施。在美洲，先進的神經外科中心和綜合醫療保健系統優先考慮臨床療效、手術效率和器械的長期性能。這種環境有利於擁有強力臨床證據和完善服務模式的器械，而採購團隊則要求提供供應鏈韌性和上市後安全性資料的相關文件。該地區的過渡性政策和支付模式也促進了圍繞綜合護理路徑和器械定價結構的談判。

對動脈瘤夾生態系中各公司的競爭策略、夥伴關係模式和創新重點進行評估性觀點。

動脈瘤夾閉術領域的競爭動態由技術差異化、監管記錄和商業性支持品質三者共同決定。主要企業正集中投資於材料科學、器械人體工學和實證醫學證據的積累，以支持臨床應用。同時，與手術中心和經銷商建立夥伴關係，開展培訓、病例觀察和收集外科醫生回饋，正成為加速產品推廣、減少部署阻力的有效途徑。

為經營團隊提供切實可行的、優先考慮的建議，以協調創新、供應鏈韌性和商業策略，從而確保永續的競爭優勢。

尋求獲得永續競爭優勢的產業領導者應採取整合策略，將技術創新、業務永續營運和與臨床醫生的合作相結合。首先，他們必須優先考慮供應鏈多元化，並透過投資本地製造和認證的契約製造夥伴關係關係來降低貿易中斷的風險。同時，他們也應建立健全的庫存和需求規劃流程，以避免即使在政策或物流衝擊的情況下也出現服務中斷。其次，他們應將研發資源投入到能夠顯著減少影像偽影並支持長期生物相容性的材料和表面技術中，同時透過有針對性的臨床合作來建立依證。

對支持研究結果的混合方法研究設計、主要和次要調查、三角測量檢驗以及局限性進行透明的解釋。

本研究採用系統性的調查方法，將一手質性研究與嚴謹的二手資訊檢驗結合。一手資料包括對執業神經外科醫師、血管專科醫生、採購經理和供應鏈經理的半結構式訪談，旨在了解醫療設備的實際使用情況、選擇因素和採購限制。這些一線觀點揭示了醫療設備的性能標準和推廣應用障礙，並被用於建構後續訪談中與供應商和分銷商的訪談問題。

簡潔的結論整合了臨床、技術和商業性要求，並明確了相關人員為確保策略地位而應採取的優先行動。

綜合以上觀察，我們認為該領域正處於十字路口。臨床技術的進步和影像主導的工作流程提高了人們對醫療設備效能的期望，而商業性和政策壓力則要求供應鏈具備韌性，並提供兼顧成本效益的價值提案。材料創新、與臨床醫師進行深入合作以及積極與監管機構溝通，正逐漸成為確立產品領先地位的有效途徑。同時，應對區域市場動態需要採取個人化的方法，尊重當地的管理體制、採購機制和臨床能力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：動脈瘤夾市場：依手術方法分類

  • 血管內
  • 開放性手術

第9章：動脈瘤夾市場：依材料分類

  • 鈷合金
  • 聚合物
  • 鈦

第10章：動脈瘤夾市場：依夾子類型分類

  • 弧形字體
  • 窗戶類型
  • 直型

第11章 動脈瘤夾市場：依應用領域分類

  • 顱內
  • 外圍

第12章 動脈瘤夾市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專業醫療中心

第13章 動脈瘤夾市場：依通路分類

  • 離線
  • 線上

第14章 動脈瘤夾市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 動脈瘤夾市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 動脈瘤夾市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國動脈瘤夾市場

第18章：中國動脈瘤夾市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Adeor Medical AG
  • Aesculap AG
  • Aesculap Inc.
  • Aroa Biosurgery Limited
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Boston Scientific Corporation
  • Cook Medical Incorporated
  • Edwards Lifesciences Corporation
  • G. Surkin & Co. Ltd.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • KLS Martin Group
  • Lemaitre Vascular Inc.
  • Medtronic plc
  • MicroVention Inc.
  • Natus Medical Incorporated
  • Peter Lazic GmbH
  • Stryker Corporation
  • Synovis Micro Companies Alliance Inc.
  • Teleflex Incorporated
  • Vycor Medical Inc.
  • WL Gore & Associates Inc.
  • Zeppelin Medical Devices
Product Code: MRR-3A68B83976BD

The Aneurysm Clips Market was valued at USD 87.20 million in 2025 and is projected to grow to USD 92.07 million in 2026, with a CAGR of 6.46%, reaching USD 135.19 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 87.20 million
Estimated Year [2026] USD 92.07 million
Forecast Year [2032] USD 135.19 million
CAGR (%) 6.46%

A focused introduction to clinical, technological, and procurement forces shaping the aneurysm clip landscape and influencing device uptake

Aneurysm clipping remains a critical component in the neurosurgical armamentarium, combining decades of technical refinement with ongoing material and procedural innovation. As clinicians balance the merits of open surgical approaches against evolving minimally invasive techniques, attention has turned to devices that maximize occlusion reliability while minimizing collateral tissue trauma and imaging artefacts. Parallel advancements in imaging, neuro-navigation, and intraoperative monitoring have increased the precision with which clips are selected and deployed, and have also raised the bar for device compatibility with digital surgical workflows.

In addition to clinical drivers, procurement and distribution dynamics now influence device selection from hospital systems to specialty centers. Manufacturers and suppliers must respond to heightened expectations for traceability, sterilization assurance, and supply continuity, while surgeons demand predictable handling characteristics and long-term biocompatibility. Consequently, product development has migrated beyond simple mechanical design to encompass material science, surface engineering, and integration with advanced surgical platforms. These changes have real implications for clinical training, procurement policy, and the design of post-market surveillance programs.

Given this evolving context, stakeholders need a concise synthesis of technological, regulatory, and commercial influences that shape decision-making across institutions. The following sections unpack these influences with an emphasis on actionable insight and sector-specific implications.

An analytical overview of the major technological, regulatory, and commercial shifts that are reshaping product development and adoption patterns in aneurysm clips

The aneurysm clip sector is experiencing a series of transformative shifts driven by technological convergence and shifting clinical preferences. Minimally invasive and image-guided interventions have grown in capability and acceptance, prompting manufacturers to re-evaluate clip geometry, radiopacity, and instrument ergonomics to support faster, more reliable deployment. At the same time, material innovations, including refined titanium alloys and polymer composites, are reducing imaging artefacts and improving biocompatibility, which in turn alters perioperative workflows and follow-up imaging strategies.

Moreover, the integration of digital systems into the operating room-from intraoperative angiography to navigation platforms-has elevated the importance of device interoperability. Regulatory frameworks have simultaneously evolved to place greater emphasis on post-market surveillance, device traceability, and clinician-reported outcomes, which shifts R&D priorities toward evidence generation and lifecycle management. Commercially, procurement channels are fragmenting as non-traditional buying models and online procurement portals gain traction alongside long-established distributor networks and direct hospital buying arrangements.

Consequently, suppliers must balance innovation with operational resilience: product differentiation through materials and design must be matched by investments in manufacturing quality, supply chain transparency, and clinical education to ensure adoption. These shifts create both opportunity and risk, making strategic clarity essential for those looking to sustain competitive advantage.

A focused assessment of how new tariff dynamics in 2025 are influencing sourcing choices, supply chain resilience, and commercial risk management across stakeholders

The introduction of new tariff measures in 2025 has compounded existing supply chain complexities for medical device stakeholders, necessitating rapid reassessment of sourcing strategies. Increased import duties affect component flows and finished goods originating from international suppliers, prompting some manufacturers to consider nearshoring or expanding domestic production capabilities as a way to control landed costs and minimize exposure to future policy shifts. At the same time, distributors and hospital procurement teams are reassessing contractual terms to mitigate margin compression and maintain service levels.

Operationally, tariffs influence inventory management and contract cadence: organizations are inclined to increase safety stock or renegotiate lead times to reduce exposure to price volatility, which has knock-on effects for working capital and storage logistics. From a competitive perspective, firms with diversified manufacturing footprints or integrated supply chains enjoy greater flexibility to absorb or offset tariff-driven cost increases without immediate price pass-through to end users. Conversely, smaller suppliers that rely heavily on imported components face acute pressure to preserve margin and may pursue strategic partnerships or consolidation to preserve market access.

Importantly, clinical institutions and purchasing groups have limited appetite for abrupt price increases, which increases scrutiny on value-added services such as clinical education, warranty provisions, and device performance guarantees. Accordingly, stakeholders should evaluate supplier resilience, contract structures, and regional production options as they navigate the evolving tariff environment and its cumulative operational impacts.

Strategic segmentation insights that explain how application, surgical technique, end user, distribution, material, and clip type shape clinical and commercial priorities

Segmentation provides a necessary lens for translating overarching trends into targeted product and commercial strategies. When the market is examined by application-distinguishing between intracranial and peripheral use cases-design priorities change: intracranial applications demand exquisite control, low-profile geometries, and imaging compatibility, while peripheral applications prioritize robustness, different sizing options, and handling characteristics tailored to vascular anatomy. In contrast, surgical technique segmentation-covering endovascular and open approaches-creates divergent pathways for device evolution, where endovascular procedures emphasize compatibility with navigation systems and catheter-based adjuncts, and open techniques retain strong requirements for mechanical reliability and tactile feedback.

End-user segmentation further refines commercialization priorities; ambulatory surgical centers, hospitals, and specialty centers each present different buying cycles, bundling requirements, and post-operative follow-up practices that influence how products are positioned and supported. Distribution channel segmentation-spanning direct sales, distributors, and online sales-affects margin structures, service expectations, and speed of deployment; direct engagement supports bespoke training and procurement integration, distributors offer breadth and regional reach, and online channels accelerate access for standardized products. Material segmentation across cobalt alloy, polymer, and titanium reveals trade-offs between strength, imaging behaviour, and biocompatibility that intersect with regulatory pathways and long-term surveillance needs. Finally, clip type segmentation-curved, fenestrated, and straight-dictates instrument compatibility, surgeon preference patterns, and inventory rationalization strategies. Together, these segmentation axes deliver a layered framework that informs product design, clinical evidence generation, and tailored commercial models.

Regional analysis highlighting distinct regulatory, clinical adoption, and commercial dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics shape both innovation pathways and commercial execution in distinct ways. In the Americas, advanced neurosurgical centers and integrated health systems prioritize clinical outcomes, procedural efficiency, and longitudinal device performance. This environment favors devices with strong clinical evidence and comprehensive service models, while procurement teams demand documentation of supply chain resilience and post-market safety data. Transitional policies and payer models in the region also drive negotiation over bundled care pathways and device pricing structures.

In Europe, Middle East & Africa, regulatory harmonization in some jurisdictions coexists with highly localized procurement processes, creating a mosaic of requirements for device approvals and commercialization. Reimbursement models vary significantly, and in several markets there is a premium placed on products that reduce procedure time or enable faster discharge. The diversity of infrastructure across the region means that distributors and local partners play a critical role in education, training, and installation support.

Meanwhile, Asia-Pacific presents a blend of high-volume clinical demand and rapidly maturing manufacturing capabilities. Several markets within the region are emphasizing domestic production and regulatory acceleration for innovative devices, which can create both competitive pressure and partnership opportunities. Adoption in the region is influenced by capacity expansion in tertiary centers, price sensitivity in public systems, and an increasing emphasis on evidence generation to support broader uptake. Collectively, these regional distinctions necessitate tailored market entry strategies and localized value propositions.

An evaluative perspective on competitive strategies, partnership models, and innovation priorities among companies operating in the aneurysm clip ecosystem

Competitive dynamics in the aneurysm clip sector are shaped by a combination of technical differentiation, regulatory track records, and the quality of commercial support. Leading players focus investment on materials science, device ergonomics, and evidence generation to support clinical adoption. At the same time, partnerships with surgical centers and distributors for training, case observation, and surgeon feedback have emerged as an effective route to accelerate adoption while reducing implementation friction.

Strategic activity also includes targeted acquisitions and co-development agreements to fill gaps in capabilities-whether that be in advanced alloy processing, polymer technology, or digital integration that enhances intraoperative decision-making. Firms that demonstrate consistent regulatory compliance and robust post-market surveillance tend to build stronger trust with hospital procurement teams and physician groups. In addition, companies that successfully align product portfolios with service offerings, such as simulation-based training and clinical data services, strengthen customer relationships and create differentiated value beyond the device itself.

Smaller and mid-sized innovators often concentrate on niche differentiation-such as unique clip geometries or material blends-while leveraging distribution partnerships to scale. For stakeholders evaluating competitive positioning, the key considerations are how material and design choices translate to clinical benefit, how regulatory and quality systems are structured, and how commercial models address the practical needs of diverse end users.

Practical and prioritized recommendations for executive teams to align innovation, supply resilience, and commercial strategies for sustained competitive advantage

Industry leaders seeking to secure durable advantage should pursue integrated strategies that align technical innovation with operational resilience and clinician engagement. First, prioritize diversification of the supply base and invest in regional manufacturing or qualified contract manufacturing relationships to reduce exposure to trade disruptions. This should be coupled with robust inventory and demand planning processes to avoid service interruptions during policy or logistical shocks. Second, allocate R&D resources to materials and surface technologies that demonstrably reduce imaging artefacts and support long-term biocompatibility, while concurrently building an evidence base through targeted clinical collaborations.

Third, strengthen post-market surveillance and clinician feedback loops to accelerate iterative product improvements and to reassure procurement stakeholders of safety and performance. Fourth, tailor commercial models to end-user segments: offer bundled services and training for hospitals and specialty centers, while optimizing standardized SKU availability and digital ordering pathways for ambulatory surgical centers. Fifth, pursue regulatory strategy proactively by aligning submissions with the most stringent jurisdictions relevant to your customer base, thereby easing entry into adjacent markets. Finally, develop clear value narratives that quantify operational benefits such as reduced procedure time, improved imaging follow-up, and lower reoperation rates, and present these narratives through clinician-led case studies and payer-oriented dossiers. These steps will collectively strengthen positioning and reduce execution risk.

A transparent description of the mixed-method research design, primary and secondary inputs, triangulation procedures, and limitations that underpin the findings

This research synthesis is grounded in a structured methodological approach that combines primary qualitative engagement with rigorous secondary source validation. Primary inputs included semi-structured interviews with practicing neurosurgeons, vascular specialists, procurement leaders, and supply chain managers to capture real-world device usage, preference drivers, and procurement constraints. These firsthand perspectives informed device performance criteria and adoption barriers, and they were used to shape follow-up questions for supplier and distributor interviews.

Secondary research involved systematic review of peer-reviewed clinical literature, regulatory agency communications, device registries, and publicly available technical documentation to validate technical claims, material performance insights, and post-market trends. Triangulation was applied across primary and secondary inputs to ensure consistency and to identify divergence that warranted deeper investigation. Analytical techniques incorporated comparative device attribute mapping, scenario analysis around supply disruption and tariff impacts, and segmentation crosswalks to align product features with end-user needs. Quality assurance processes included expert peer review, methodological transparency, and sensitivity checks to highlight areas of higher uncertainty. Limitations include potential variability in regional regulatory interpretation and institution-specific purchasing policies, which the report addresses by providing contextualized scenarios rather than universal prescriptions.

A concise conclusion that synthesizes clinical, technical, and commercial imperatives and clarifies priority actions for stakeholders to secure strategic positioning

The cumulative observations point to a sector at a crossroads: clinical advancements and imaging-driven workflows are raising expectations for device performance, while commercial and policy pressures demand supply chain resilience and cost-aware value propositions. Material innovation, informed clinician collaboration, and proactive regulatory engagement emerge as consistent levers for successful product leadership. At the same time, geographic market dynamics require tailored approaches that respect local regulatory regimes, procurement mechanisms, and clinical capacity.

Taken together, these insights suggest that success will favor organizations that combine differentiated device attributes with robust operational capabilities and sustained clinician partnerships. Investment in evidence generation and in systems that reduce exposure to supply disruption will be especially important in the current environment. For stakeholders across the value chain, the imperative is clear: align product development with the pragmatic realities of hospital and specialty center operations, and translate clinical benefits into tangible operational and patient-care improvements. Doing so will facilitate adoption and reduce commercial friction, positioning organizations to capture strategic opportunities as the clinical and policy landscape continues to evolve.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Aneurysm Clips Market, by Surgical Technique

  • 8.1. Endovascular
  • 8.2. Open

9. Aneurysm Clips Market, by Material

  • 9.1. Cobalt Alloy
  • 9.2. Polymer
  • 9.3. Titanium

10. Aneurysm Clips Market, by Clip Type

  • 10.1. Curved
  • 10.2. Fenestrated
  • 10.3. Straight

11. Aneurysm Clips Market, by Application

  • 11.1. Intracranial
  • 11.2. Peripheral

12. Aneurysm Clips Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Specialty Centers

13. Aneurysm Clips Market, by Distribution Channel

  • 13.1. Offline
  • 13.2. Online

14. Aneurysm Clips Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Aneurysm Clips Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Aneurysm Clips Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Aneurysm Clips Market

18. China Aneurysm Clips Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Adeor Medical AG
  • 19.6. Aesculap AG
  • 19.7. Aesculap Inc.
  • 19.8. Aroa Biosurgery Limited
  • 19.9. B. Braun Melsungen AG
  • 19.10. Baxter International Inc.
  • 19.11. Boston Scientific Corporation
  • 19.12. Cook Medical Incorporated
  • 19.13. Edwards Lifesciences Corporation
  • 19.14. G. Surkin & Co. Ltd.
  • 19.15. Integra LifeSciences Holdings Corporation
  • 19.16. Johnson & Johnson
  • 19.17. KLS Martin Group
  • 19.18. Lemaitre Vascular Inc.
  • 19.19. Medtronic plc
  • 19.20. MicroVention Inc.
  • 19.21. Natus Medical Incorporated
  • 19.22. Peter Lazic GmbH
  • 19.23. Stryker Corporation
  • 19.24. Synovis Micro Companies Alliance Inc.
  • 19.25. Teleflex Incorporated
  • 19.26. Vycor Medical Inc.
  • 19.27. W. L. Gore & Associates Inc.
  • 19.28. Zeppelin Medical Devices

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANEURYSM CLIPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANEURYSM CLIPS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANEURYSM CLIPS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES ANEURYSM CLIPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA ANEURYSM CLIPS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANEURYSM CLIPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY ENDOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY ENDOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY ENDOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY COBALT ALLOY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY COBALT ALLOY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY COBALT ALLOY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY CURVED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY CURVED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY CURVED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY FENESTRATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY FENESTRATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY FENESTRATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY STRAIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY STRAIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY STRAIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY INTRACRANIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY INTRACRANIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY INTRACRANIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS ANEURYSM CLIPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA ANEURYSM CLIPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. GCC ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GCC ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 120. GCC ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. GCC ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. GCC ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. GCC ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. GCC ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. G7 ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. G7 ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 141. G7 ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. G7 ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. G7 ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. G7 ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. G7 ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. NATO ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. NATO ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 148. NATO ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. NATO ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. NATO ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. NATO ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. NATO ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANEURYSM CLIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES ANEURYSM CLIPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA ANEURYSM CLIPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA ANEURYSM CLIPS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA ANEURYSM CLIPS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA ANEURYSM CLIPS MARKET SIZE, BY CLIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA ANEURYSM CLIPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA ANEURYSM CLIPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA ANEURYSM CLIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)